Skip to main content
OpenTrials
Completed

NCT Number: NCT00222703

Enhancing Tobacco Abstinence Following Hospitalization

The primary aim of this study is to examine the efficacy of a 12-week nurse-delivered relapse management intervention designed with conceptual underpinnings from Self-efficacy Theory to enhance smoking abstinence of hospitalized smokers following their hospital discharge. Specifically this study asks, does a 12-week Self-efficacy Theory driven relapse management intervention enhance smoking abstinence following hospitalization by increasing smoking abstinence point prevalence as measured by carbon monoxide validated self-reports of smoking, when compared to subjects receiving only enhanced usual care?

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Pittsburgh

Pittsburgh, Pennsylvania, 15261, United States

About this study

A randomized controlled two-group design with an intent-to-treat approach for handling protocol deviations will be used to examine the primary aim of this project. The sample will consist of 80 consenting smokers prospectively recruited during hospitalization. Subjects will be randomly assigned by equal allocation to an intervention group or an enhanced usual only group. A baseline adaptive randomization procedure will adjust the random equal ratio of treatment assignment to maintain sampling balance of the groups for race (White/Black/Other), gender (male/female), and three comorbid categories (only tobacco related illnesses/ tobacco related and unrelated to tobacco illnesses/ unrelated to tobacco illnesses). All subjects will receive enhanced usual care, which will consist of receiving a supportive message to quit smoking and smoking cessation materials. Subjects assigned to the intervention group will receive 9 intervention sessions with a nurse aimed to enhance their self-efficacy in self-management of tobacco abstinence. These sessions will occur over 12 weeks following hospital discharge. All but the initial session will occur by telephone. Subjects will be asked to participate with follow-up activities 12 weeks and 24 weeks following their hospital discharge, which requires the measurement of exhaled carbon monoxide and the completion of questionnaires by self-administration and interview with study personnel. Subjects will exit from study following the 24-week follow-up.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • smoked one cigarette within 30 days of hospital admission
  • admission to a medical/surgical patient care unit
  • 18 years of age or older

Exclusion criteria

  • diagnosis of cancer in a terminal state,
  • under evaluation for organ transplantation or awaiting transplantation,
  • cerebral vascular disorders,
  • senile dementia,
  • Alzheimer's disease,
  • abstinence from smoking greater than one month,
  • non-English speaking,
  • lack of a home telephone,
  • lack of a mailing address,
  • lack of any ability to participate with self-care activities,
  • and transfer to a rehabilitation hospital or nursing home following their hospital admission.

Treatment and study plan

Smoking relapse prevention

Behavioral

Primary outcomes

  1. Self reported smoking status validated by exhaled CO

Secondary outcomes

  1. Time to smoking lapse

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Collaborators

  • Eta Chapter, Sigma Theta Tau
  • National Institute of Nursing Research (NINR)
  • Pauline Thompson Clinical Research Award, Nursing Foundation of Pennsylvania

Registry information

Important dates

Study start
2002
Study completion
2005
First posted
Sep 22, 2005
Registry last updated
Sep 22, 2005

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.